Open Life Sciences-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2202098, encodeId=3d39220209810, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是主编或编辑直接决定？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Tue May 07 00:13:15 CST 2024, time=2024-05-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1200925, encodeId=462f12009251a, content=Required Reviews Completed一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89a2575885, createdName=1259293fm78暂无昵称, createdTime=Wed Mar 09 16:15:44 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199506, encodeId=945a2199506ee, content=请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Sat Apr 20 22:43:16 CST 2024, time=2024-04-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2201104, encodeId=55ba22011047a, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=275d5308532, createdName=14880e46m15(暂无昵称), createdTime=Mon Apr 29 17:29:43 CST 2024, time=2024-04-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2197397, encodeId=d5d2219e39734, content=3.10投的，4.8了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Mon Apr 08 15:15:11 CST 2024, time=2024-04-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2164982, encodeId=ca952164982e6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：中医药;组学 经验分享：2023.08.17 Submitted 2023.08.22 Editor Invited 2023.09.01 With Editor 2023.09.03 Under Review 2023.09.18 Under Review 2023.09.21 Under Review 2023.09.22 Under Review 2023.10.06 Under Review 2023.10.10 Decision in Process 2023.10.10 Revise 2023.10.18 Revised Manuscript Submitted 2023.10.19 With Editor 2023.10.22 Decision in Process 2023.10.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36a58750083, createdName=ms1000002064329160, createdTime=Thu Oct 26 08:59:24 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157145, encodeId=ed20215e145a6, content=6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Mon Sep 11 15:34:48 CST 2023, time=2023-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1064223, encodeId=9dda106422349, content=刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b9c5444274, createdName=ms7000001748793110, createdTime=Wed Oct 27 00:14:15 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160003, encodeId=97172160003a8, content=请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Wed Sep 27 10:19:38 CST 2023, time=2023-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125120, encodeId=f7b72125120e9, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肝病;肝衰竭;中西医 经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46868485540, createdName=ms7000001641226377, createdTime=Tue Apr 11 15:53:03 CST 2023, time=2023-04-11, status=1, ipAttribution=广西)]

2024-05-07 ms7000001126545693 来自广西

审稿速度:2.0 | 投稿命中率:50.0
经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是主编或编辑直接决定？

28 0

[GetPortalCommentsPageByObjectIdResponse(id=2202098, encodeId=3d39220209810, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是主编或编辑直接决定？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Tue May 07 00:13:15 CST 2024, time=2024-05-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1200925, encodeId=462f12009251a, content=Required Reviews Completed一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89a2575885, createdName=1259293fm78暂无昵称, createdTime=Wed Mar 09 16:15:44 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199506, encodeId=945a2199506ee, content=请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Sat Apr 20 22:43:16 CST 2024, time=2024-04-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2201104, encodeId=55ba22011047a, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=275d5308532, createdName=14880e46m15(暂无昵称), createdTime=Mon Apr 29 17:29:43 CST 2024, time=2024-04-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2197397, encodeId=d5d2219e39734, content=3.10投的，4.8了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Mon Apr 08 15:15:11 CST 2024, time=2024-04-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2164982, encodeId=ca952164982e6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：中医药;组学 经验分享：2023.08.17 Submitted 2023.08.22 Editor Invited 2023.09.01 With Editor 2023.09.03 Under Review 2023.09.18 Under Review 2023.09.21 Under Review 2023.09.22 Under Review 2023.10.06 Under Review 2023.10.10 Decision in Process 2023.10.10 Revise 2023.10.18 Revised Manuscript Submitted 2023.10.19 With Editor 2023.10.22 Decision in Process 2023.10.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36a58750083, createdName=ms1000002064329160, createdTime=Thu Oct 26 08:59:24 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157145, encodeId=ed20215e145a6, content=6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Mon Sep 11 15:34:48 CST 2023, time=2023-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1064223, encodeId=9dda106422349, content=刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b9c5444274, createdName=ms7000001748793110, createdTime=Wed Oct 27 00:14:15 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160003, encodeId=97172160003a8, content=请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Wed Sep 27 10:19:38 CST 2023, time=2023-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125120, encodeId=f7b72125120e9, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肝病;肝衰竭;中西医 经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46868485540, createdName=ms7000001641226377, createdTime=Tue Apr 11 15:53:03 CST 2023, time=2023-04-11, status=1, ipAttribution=广西)]

2022-03-09 1259293fm78暂无昵称

Required Reviews Completed一般多久啊

46 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202098, encodeId=3d39220209810, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是主编或编辑直接决定？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Tue May 07 00:13:15 CST 2024, time=2024-05-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1200925, encodeId=462f12009251a, content=Required Reviews Completed一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89a2575885, createdName=1259293fm78暂无昵称, createdTime=Wed Mar 09 16:15:44 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199506, encodeId=945a2199506ee, content=请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Sat Apr 20 22:43:16 CST 2024, time=2024-04-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2201104, encodeId=55ba22011047a, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=275d5308532, createdName=14880e46m15(暂无昵称), createdTime=Mon Apr 29 17:29:43 CST 2024, time=2024-04-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2197397, encodeId=d5d2219e39734, content=3.10投的，4.8了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Mon Apr 08 15:15:11 CST 2024, time=2024-04-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2164982, encodeId=ca952164982e6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：中医药;组学 经验分享：2023.08.17 Submitted 2023.08.22 Editor Invited 2023.09.01 With Editor 2023.09.03 Under Review 2023.09.18 Under Review 2023.09.21 Under Review 2023.09.22 Under Review 2023.10.06 Under Review 2023.10.10 Decision in Process 2023.10.10 Revise 2023.10.18 Revised Manuscript Submitted 2023.10.19 With Editor 2023.10.22 Decision in Process 2023.10.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36a58750083, createdName=ms1000002064329160, createdTime=Thu Oct 26 08:59:24 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157145, encodeId=ed20215e145a6, content=6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Mon Sep 11 15:34:48 CST 2023, time=2023-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1064223, encodeId=9dda106422349, content=刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b9c5444274, createdName=ms7000001748793110, createdTime=Wed Oct 27 00:14:15 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160003, encodeId=97172160003a8, content=请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Wed Sep 27 10:19:38 CST 2023, time=2023-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125120, encodeId=f7b72125120e9, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肝病;肝衰竭;中西医 经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46868485540, createdName=ms7000001641226377, createdTime=Tue Apr 11 15:53:03 CST 2023, time=2023-04-11, status=1, ipAttribution=广西)]

2024-04-20 ms7000001126545693 来自广西

请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。

40 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202098, encodeId=3d39220209810, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是主编或编辑直接决定？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Tue May 07 00:13:15 CST 2024, time=2024-05-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1200925, encodeId=462f12009251a, content=Required Reviews Completed一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89a2575885, createdName=1259293fm78暂无昵称, createdTime=Wed Mar 09 16:15:44 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199506, encodeId=945a2199506ee, content=请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Sat Apr 20 22:43:16 CST 2024, time=2024-04-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2201104, encodeId=55ba22011047a, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=275d5308532, createdName=14880e46m15(暂无昵称), createdTime=Mon Apr 29 17:29:43 CST 2024, time=2024-04-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2197397, encodeId=d5d2219e39734, content=3.10投的，4.8了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Mon Apr 08 15:15:11 CST 2024, time=2024-04-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2164982, encodeId=ca952164982e6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：中医药;组学 经验分享：2023.08.17 Submitted 2023.08.22 Editor Invited 2023.09.01 With Editor 2023.09.03 Under Review 2023.09.18 Under Review 2023.09.21 Under Review 2023.09.22 Under Review 2023.10.06 Under Review 2023.10.10 Decision in Process 2023.10.10 Revise 2023.10.18 Revised Manuscript Submitted 2023.10.19 With Editor 2023.10.22 Decision in Process 2023.10.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36a58750083, createdName=ms1000002064329160, createdTime=Thu Oct 26 08:59:24 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157145, encodeId=ed20215e145a6, content=6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Mon Sep 11 15:34:48 CST 2023, time=2023-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1064223, encodeId=9dda106422349, content=刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b9c5444274, createdName=ms7000001748793110, createdTime=Wed Oct 27 00:14:15 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160003, encodeId=97172160003a8, content=请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Wed Sep 27 10:19:38 CST 2023, time=2023-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125120, encodeId=f7b72125120e9, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肝病;肝衰竭;中西医 经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46868485540, createdName=ms7000001641226377, createdTime=Tue Apr 11 15:53:03 CST 2023, time=2023-04-11, status=1, ipAttribution=广西)]

2024-04-29 14880e46m15(暂无昵称) 来自河南省

审稿速度:12.0 | 投稿命中率:5.0
经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。

32 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202098, encodeId=3d39220209810, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是主编或编辑直接决定？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Tue May 07 00:13:15 CST 2024, time=2024-05-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1200925, encodeId=462f12009251a, content=Required Reviews Completed一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89a2575885, createdName=1259293fm78暂无昵称, createdTime=Wed Mar 09 16:15:44 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199506, encodeId=945a2199506ee, content=请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Sat Apr 20 22:43:16 CST 2024, time=2024-04-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2201104, encodeId=55ba22011047a, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=275d5308532, createdName=14880e46m15(暂无昵称), createdTime=Mon Apr 29 17:29:43 CST 2024, time=2024-04-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2197397, encodeId=d5d2219e39734, content=3.10投的，4.8了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Mon Apr 08 15:15:11 CST 2024, time=2024-04-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2164982, encodeId=ca952164982e6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：中医药;组学 经验分享：2023.08.17 Submitted 2023.08.22 Editor Invited 2023.09.01 With Editor 2023.09.03 Under Review 2023.09.18 Under Review 2023.09.21 Under Review 2023.09.22 Under Review 2023.10.06 Under Review 2023.10.10 Decision in Process 2023.10.10 Revise 2023.10.18 Revised Manuscript Submitted 2023.10.19 With Editor 2023.10.22 Decision in Process 2023.10.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36a58750083, createdName=ms1000002064329160, createdTime=Thu Oct 26 08:59:24 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157145, encodeId=ed20215e145a6, content=6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Mon Sep 11 15:34:48 CST 2023, time=2023-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1064223, encodeId=9dda106422349, content=刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b9c5444274, createdName=ms7000001748793110, createdTime=Wed Oct 27 00:14:15 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160003, encodeId=97172160003a8, content=请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Wed Sep 27 10:19:38 CST 2023, time=2023-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125120, encodeId=f7b72125120e9, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肝病;肝衰竭;中西医 经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46868485540, createdName=ms7000001641226377, createdTime=Tue Apr 11 15:53:03 CST 2023, time=2023-04-11, status=1, ipAttribution=广西)]

2024-04-08 ms7000001126545693 来自广西

3.10投的，4.8了还没分配编辑

33 0

[GetPortalCommentsPageByObjectIdResponse(id=2202098, encodeId=3d39220209810, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是主编或编辑直接决定？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Tue May 07 00:13:15 CST 2024, time=2024-05-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1200925, encodeId=462f12009251a, content=Required Reviews Completed一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89a2575885, createdName=1259293fm78暂无昵称, createdTime=Wed Mar 09 16:15:44 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199506, encodeId=945a2199506ee, content=请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Sat Apr 20 22:43:16 CST 2024, time=2024-04-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2201104, encodeId=55ba22011047a, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=275d5308532, createdName=14880e46m15(暂无昵称), createdTime=Mon Apr 29 17:29:43 CST 2024, time=2024-04-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2197397, encodeId=d5d2219e39734, content=3.10投的，4.8了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Mon Apr 08 15:15:11 CST 2024, time=2024-04-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2164982, encodeId=ca952164982e6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：中医药;组学 经验分享：2023.08.17 Submitted 2023.08.22 Editor Invited 2023.09.01 With Editor 2023.09.03 Under Review 2023.09.18 Under Review 2023.09.21 Under Review 2023.09.22 Under Review 2023.10.06 Under Review 2023.10.10 Decision in Process 2023.10.10 Revise 2023.10.18 Revised Manuscript Submitted 2023.10.19 With Editor 2023.10.22 Decision in Process 2023.10.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36a58750083, createdName=ms1000002064329160, createdTime=Thu Oct 26 08:59:24 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157145, encodeId=ed20215e145a6, content=6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Mon Sep 11 15:34:48 CST 2023, time=2023-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1064223, encodeId=9dda106422349, content=刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b9c5444274, createdName=ms7000001748793110, createdTime=Wed Oct 27 00:14:15 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160003, encodeId=97172160003a8, content=请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Wed Sep 27 10:19:38 CST 2023, time=2023-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125120, encodeId=f7b72125120e9, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肝病;肝衰竭;中西医 经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46868485540, createdName=ms7000001641226377, createdTime=Tue Apr 11 15:53:03 CST 2023, time=2023-04-11, status=1, ipAttribution=广西)]

2023-10-26 ms1000002064329160 来自江苏省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：中医药;组学
经验分享：2023.08.17 Submitted
2023.08.22 Editor Invited
2023.09.01 With Editor
2023.09.03 Under Review
2023.09.18 Under Review
2023.09.21 Under Review
2023.09.22 Under Review
2023.10.06 Under Review
2023.10.10 Decision in Process
2023.10.10 Revise
2023.10.18 Revised Manuscript Submitted
2023.10.19 With Editor
2023.10.22 Decision in Process
2023.10.23 Accept

54 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202098, encodeId=3d39220209810, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是主编或编辑直接决定？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Tue May 07 00:13:15 CST 2024, time=2024-05-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1200925, encodeId=462f12009251a, content=Required Reviews Completed一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89a2575885, createdName=1259293fm78暂无昵称, createdTime=Wed Mar 09 16:15:44 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199506, encodeId=945a2199506ee, content=请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Sat Apr 20 22:43:16 CST 2024, time=2024-04-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2201104, encodeId=55ba22011047a, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=275d5308532, createdName=14880e46m15(暂无昵称), createdTime=Mon Apr 29 17:29:43 CST 2024, time=2024-04-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2197397, encodeId=d5d2219e39734, content=3.10投的，4.8了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Mon Apr 08 15:15:11 CST 2024, time=2024-04-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2164982, encodeId=ca952164982e6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：中医药;组学 经验分享：2023.08.17 Submitted 2023.08.22 Editor Invited 2023.09.01 With Editor 2023.09.03 Under Review 2023.09.18 Under Review 2023.09.21 Under Review 2023.09.22 Under Review 2023.10.06 Under Review 2023.10.10 Decision in Process 2023.10.10 Revise 2023.10.18 Revised Manuscript Submitted 2023.10.19 With Editor 2023.10.22 Decision in Process 2023.10.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36a58750083, createdName=ms1000002064329160, createdTime=Thu Oct 26 08:59:24 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157145, encodeId=ed20215e145a6, content=6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Mon Sep 11 15:34:48 CST 2023, time=2023-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1064223, encodeId=9dda106422349, content=刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b9c5444274, createdName=ms7000001748793110, createdTime=Wed Oct 27 00:14:15 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160003, encodeId=97172160003a8, content=请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Wed Sep 27 10:19:38 CST 2023, time=2023-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125120, encodeId=f7b72125120e9, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肝病;肝衰竭;中西医 经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46868485540, createdName=ms7000001641226377, createdTime=Tue Apr 11 15:53:03 CST 2023, time=2023-04-11, status=1, ipAttribution=广西)]

2023-09-11 156GRoK0535(apple) 来自福建省

6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！

47 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202098, encodeId=3d39220209810, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是主编或编辑直接决定？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Tue May 07 00:13:15 CST 2024, time=2024-05-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1200925, encodeId=462f12009251a, content=Required Reviews Completed一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89a2575885, createdName=1259293fm78暂无昵称, createdTime=Wed Mar 09 16:15:44 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199506, encodeId=945a2199506ee, content=请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Sat Apr 20 22:43:16 CST 2024, time=2024-04-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2201104, encodeId=55ba22011047a, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=275d5308532, createdName=14880e46m15(暂无昵称), createdTime=Mon Apr 29 17:29:43 CST 2024, time=2024-04-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2197397, encodeId=d5d2219e39734, content=3.10投的，4.8了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Mon Apr 08 15:15:11 CST 2024, time=2024-04-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2164982, encodeId=ca952164982e6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：中医药;组学 经验分享：2023.08.17 Submitted 2023.08.22 Editor Invited 2023.09.01 With Editor 2023.09.03 Under Review 2023.09.18 Under Review 2023.09.21 Under Review 2023.09.22 Under Review 2023.10.06 Under Review 2023.10.10 Decision in Process 2023.10.10 Revise 2023.10.18 Revised Manuscript Submitted 2023.10.19 With Editor 2023.10.22 Decision in Process 2023.10.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36a58750083, createdName=ms1000002064329160, createdTime=Thu Oct 26 08:59:24 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157145, encodeId=ed20215e145a6, content=6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Mon Sep 11 15:34:48 CST 2023, time=2023-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1064223, encodeId=9dda106422349, content=刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b9c5444274, createdName=ms7000001748793110, createdTime=Wed Oct 27 00:14:15 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160003, encodeId=97172160003a8, content=请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Wed Sep 27 10:19:38 CST 2023, time=2023-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125120, encodeId=f7b72125120e9, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肝病;肝衰竭;中西医 经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46868485540, createdName=ms7000001641226377, createdTime=Tue Apr 11 15:53:03 CST 2023, time=2023-04-11, status=1, ipAttribution=广西)]

2021-10-27 ms7000001748793110

刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。

101 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202098, encodeId=3d39220209810, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是主编或编辑直接决定？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Tue May 07 00:13:15 CST 2024, time=2024-05-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1200925, encodeId=462f12009251a, content=Required Reviews Completed一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89a2575885, createdName=1259293fm78暂无昵称, createdTime=Wed Mar 09 16:15:44 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199506, encodeId=945a2199506ee, content=请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Sat Apr 20 22:43:16 CST 2024, time=2024-04-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2201104, encodeId=55ba22011047a, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=275d5308532, createdName=14880e46m15(暂无昵称), createdTime=Mon Apr 29 17:29:43 CST 2024, time=2024-04-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2197397, encodeId=d5d2219e39734, content=3.10投的，4.8了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Mon Apr 08 15:15:11 CST 2024, time=2024-04-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2164982, encodeId=ca952164982e6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：中医药;组学 经验分享：2023.08.17 Submitted 2023.08.22 Editor Invited 2023.09.01 With Editor 2023.09.03 Under Review 2023.09.18 Under Review 2023.09.21 Under Review 2023.09.22 Under Review 2023.10.06 Under Review 2023.10.10 Decision in Process 2023.10.10 Revise 2023.10.18 Revised Manuscript Submitted 2023.10.19 With Editor 2023.10.22 Decision in Process 2023.10.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36a58750083, createdName=ms1000002064329160, createdTime=Thu Oct 26 08:59:24 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157145, encodeId=ed20215e145a6, content=6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Mon Sep 11 15:34:48 CST 2023, time=2023-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1064223, encodeId=9dda106422349, content=刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b9c5444274, createdName=ms7000001748793110, createdTime=Wed Oct 27 00:14:15 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160003, encodeId=97172160003a8, content=请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Wed Sep 27 10:19:38 CST 2023, time=2023-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125120, encodeId=f7b72125120e9, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肝病;肝衰竭;中西医 经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46868485540, createdName=ms7000001641226377, createdTime=Tue Apr 11 15:53:03 CST 2023, time=2023-04-11, status=1, ipAttribution=广西)]

2023-09-27 ms7000000631832992

请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？

56 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2202098, encodeId=3d39220209810, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问各位大佬，返修回去后还给会送给原来的审稿人再审吗？，还是主编或编辑直接决定？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Tue May 07 00:13:15 CST 2024, time=2024-05-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1200925, encodeId=462f12009251a, content=Required Reviews Completed一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d89a2575885, createdName=1259293fm78暂无昵称, createdTime=Wed Mar 09 16:15:44 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199506, encodeId=945a2199506ee, content=请问各位友友，Required Reviews Completed是什么状态呀，会不会接着又是拒稿啊，4月10号才分配编辑，没过几天就外审了，4月17号就是Required Reviews Completed，被拒稿拒出阴影了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Sat Apr 20 22:43:16 CST 2024, time=2024-04-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2201104, encodeId=55ba22011047a, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：我真服了，投快俩月，一直是投稿状态，巨慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=275d5308532, createdName=14880e46m15(暂无昵称), createdTime=Mon Apr 29 17:29:43 CST 2024, time=2024-04-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2197397, encodeId=d5d2219e39734, content=3.10投的，4.8了还没分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bb8621852, createdName=ms7000001126545693, createdTime=Mon Apr 08 15:15:11 CST 2024, time=2024-04-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2164982, encodeId=ca952164982e6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：中医药;组学 经验分享：2023.08.17 Submitted 2023.08.22 Editor Invited 2023.09.01 With Editor 2023.09.03 Under Review 2023.09.18 Under Review 2023.09.21 Under Review 2023.09.22 Under Review 2023.10.06 Under Review 2023.10.10 Decision in Process 2023.10.10 Revise 2023.10.18 Revised Manuscript Submitted 2023.10.19 With Editor 2023.10.22 Decision in Process 2023.10.23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36a58750083, createdName=ms1000002064329160, createdTime=Thu Oct 26 08:59:24 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157145, encodeId=ed20215e145a6, content=6月21投稿，7月13号外审，8月24号外审回来修稿，8月29号修稿后提交，9月4号接收，中间有写过催稿信，感觉编辑都很友好，会回复信件而且也加快进度了，感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Mon Sep 11 15:34:48 CST 2023, time=2023-09-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1064223, encodeId=9dda106422349, content=刚发表一篇。4月15号投的，一个月才送review，一审花了快4个月，四个申稿人，两周时间要修回，二审两周给接收意见，两周proof，紧接着online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b9c5444274, createdName=ms7000001748793110, createdTime=Wed Oct 27 00:14:15 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160003, encodeId=97172160003a8, content=请问各位大佬状态为Editor Declined Invitation是什么意思啊？要拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Wed Sep 27 10:19:38 CST 2023, time=2023-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125120, encodeId=f7b72125120e9, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肝病;肝衰竭;中西医 经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46868485540, createdName=ms7000001641226377, createdTime=Tue Apr 11 15:53:03 CST 2023, time=2023-04-11, status=1, ipAttribution=广西)]

2023-04-11 ms7000001641226377 来自广西

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：肝病;肝衰竭;中西医
经验分享：22年11月投稿，1修是2月，2修改图片格式等等，4月初录用，19000的版面费，总体来说还可以

59 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务